Drug Profile
Atezolizumab companion diagnostic - Roche
Alternative Names: MPDL3280A companion diagnostic; PD-L1 rabbit monoclonal immunohistochemistry antibody; Roche Tissue Diagnostics IHC assay; SP 142 immunohistochemistry antibody; Ventana PD-L1 (SP142) AssayLatest Information Update: 28 Sep 2022
Price :
$50
*
At a glance
- Originator Roche
- Developer Roche; Roche Tissue Diagnostics
- Class Monoclonal antibody diagnostics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Bladder cancer; Breast cancer; Non-small cell lung cancer
Most Recent Events
- 28 Sep 2022 No recent reports of development identified for clinical-Phase-Unknown development in Breast-cancer(Diagnosis) in Europe
- 13 Jul 2021 Ventana Medical Systems changed its name to Roche Tissue Diagnostics
- 15 Dec 2020 Registered for Non-small cell lung cancer (Diagnosis) in Japan (unspecified route)